In the largest non-pharmacological trial ever in children with fragile X syndrome (FXS), UC Davis researchers found that large-scale, in-home cognitive interventions are feasible and may be beneficial for individuals with the syndrome and potentially other intellectual disabilities.
Leaders of UC Davis Healthannounced Thursday that the state of California has awarded its scientists and clinicians $8.8 million – or almost 42 percent – of a $21 million package earmarked for the study of Alzheimer’s disease.
Picking strawberries takes speed, stamina, and skill. Can a robot do it? Professor David Slaughter at the University of California, Davis demonstrates how future farmers might employ emerging technology.
An enzyme inhibitor developed by Bruce Hammock, PhD, professor of entomology, and colleagues at University of California (UC), Davis, reduced inflammation in the brains of mice born to mothers with maternal immune activation as described in a study in PNAS.
UC Davis researchersannounced Tuesday that, after studying brain tissue from 423 Americans of Latino, African and non-Hispanic white descent, they have discovered startling variations in the causes of dementia among people of different races and ethnicities.
Seventeen-year-old Justin Silver was five when he was diagnosed with fragile X syndrome. Despite living across the country in New York, the family traveled to the UC Davis MIND Institute in Sacramento, Calif., where they met the world’s leading experts in the field.